Analysis: Medicamen Biotech Limited

NSE:MEDICAMEQ Pharma - Formulators Market cap: ₹352 cr

Research report

companyname: Medicamen Biotech Limited ticker: MEDICAMEQ sector: Pharmaceuticals Medicamen Biotech Limited (MBL) is a pharmaceutical company that develops, manufactures, and markets finished dosage forms, including tablets, capsules, syrups, and oncology products. The company was established in December 1993 and operates from three manufacturing facilities in India. Its business is split between domestic and international markets, with approximately 80% of sales coming from exports as of FY2025...

Read the full report →
RS rating: 77 Stage: Stage 1

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Medicamen Biotech Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.